The Science
What are stem cells, really?
Stem cells are the body’s undifferentiated repair cells. This page explains the three cell products Allure Stem Cell works with, how they are sourced and tested, and what the research does and does not yet show.
What is a mesenchymal stem cell?
Mesenchymal stem cells (MSCs) are adult stem cells found in tissues such as umbilical cord, bone marrow, and fat. In the laboratory they can self-renew and give rise to cell types including bone, cartilage, and fat. In the body, research focuses less on MSCs becoming new tissue and more on the signals they release: growth factors and immune-modulating molecules that are studied for their effect on inflammation.
Allure Stem Cell uses allogeneic MSCs, meaning they come from screened, consenting donors rather than from your own body. Most are derived from umbilical cord tissue (Wharton’s jelly). Donors undergo infectious-disease testing, and the cells are expanded in cGMP-compliant laboratories.
What is an exosome?
Exosomes are tiny vesicles, far smaller than a cell, that cells release to communicate with one another. They carry proteins, lipids, and RNA. Exosomes used at Allure Stem Cell are derived from MSC cultures and contain no living cells, which is why they are generally considered to carry minimal risk of immune reaction. Research into what exosome infusions do in people is active but early.
What are MUSE cells?
Multilineage-differentiating stress-enduring (MUSE) cells are a stress-tolerant stem cell population first described by Japanese researchers in 2010. In laboratory conditions they can give rise to cells of all three germ layers. What that means for patients is still being studied in clinical trials; outside trials, their use is investigational.
How are the cells tested?
Every batch used at Allure Stem Cell is tested for viability, identity, sterility, and potency before release, and you receive the certificate of analysis for your treatment. Testing confirms what is in the vial; it does not establish what the cells will do for a particular condition.
What the research does not yet show
Outside bone marrow transplantation for blood cancers, stem cell therapies are not FDA-approved. Clinical trials are ongoing in orthopedics, autoimmune disease, neurology, and post-surgical recovery, with mixed and still-maturing results. We will tell you where the evidence is strong, where it is thin, and where it does not exist. That conversation is the core of your free consultation.